Norditropin Flexpro (Somatropin)

Somatropin, the active ingredient in Norditropin Flexpro, is a growth hormone presented as a biologic for subcutaneous use. It is prescribed for individuals with growth hormone deficiency, supporting normal growth in children and metabolic functions in adults. Norditropin Flexpro is a recombinant human growth hormone indicated for both pediatric and adult patients who lack adequate endogenous production.

GNH USA supplies Norditropin Flexpro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Norditropin Flexpro is a recombinant growth hormone used to treat conditions related to deficient endogenous hormone production. - Growth hormone deficiency in children: promotes linear growth and improves height velocity. - Growth hormone deficiency in adults: enhances body composition, reduces cardiovascular risk factors, and improves quality of life.

Somatropin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Injection site pain or erythema: localized discomfort after subcutaneous administration. - Headache: mild to moderate intensity, often transient. - Joint or muscle pain: musculoskeletal discomfort reported by some patients. - Edema: peripheral swelling, particularly in the lower extremities. - Hyperglycemia: elevated blood glucose levels, especially in predisposed individuals.

Serious or Rare Side Effects: - Intracranial hypertension: signs include severe headache, visual disturbances, and nausea. - Slipped epiphysis (growth plate closure): premature closure of growth plates in children. - Severe allergic reaction: anaphylaxis, urticaria, or angioedema requiring immediate medical attention.

When prescribing Norditropin Flexpro, clinicians should consider several safety measures. - Monitor glucose: assess blood sugar regularly, especially in diabetic patients. - Assess intracranial pressure: watch for persistent headaches or visual changes. - Evaluate growth plates: periodic radiographs in children to detect premature closure. - Review concomitant hormone therapy: adjust doses of thyroid or glucocorticoids as needed. - Store at 2‑8°C: keep refrigerated, protect from light, do not freeze or shake the product.

Somatropin can interact with other medications, influencing efficacy or safety.

Major Interactions (Avoid): - High‑dose glucocorticoids: may blunt growth‑promoting effects. - Insulin or oral hypoglycemics: increased risk of hypoglycemia; dose adjustments may be required.

Moderate Interactions (Monitor Closely): - Estrogen therapy: may reduce IGF‑1 response, necessitating dose titration. - Thyroid hormone replacement: requires monitoring of thyroid function tests. - Antidiabetic agents: may need closer glucose monitoring.